IDH2 GENE MUTATION
Clinical trials for IDH2 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new IDH2 GENE MUTATION trials appear
Sign up with your email to follow new studies for IDH2 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young brain cancer patients in Early-Stage trial
Disease control OngoingThis early-stage study is testing a new two-drug combination (BGB-290 and temozolomide) for adolescents and young adults with specific types of brain tumors that have returned or are newly diagnosed. The main goal is to find the safest dose and understand the side effects. Resear…
Matched conditions: IDH2 GENE MUTATION
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC
-
Scientists probe experimental Drug's path into brain tumors
Knowledge-focused OngoingThis early study aims to understand if an experimental drug called niraparib reaches brain tumor tissue effectively. It involves 16 adults with recurrent, slow-growing brain tumors (gliomas) who are already scheduled for surgery. Researchers will measure how much of the drug gets…
Matched conditions: IDH2 GENE MUTATION
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC